Mohammad Sheibani

58 papers receiving 745 citations

Mohammad Sheibani's Hit Papers

Doxorubicin-Induced Cardiotoxicity: An Overview on Pre-clinical Therapeutic Approaches 2022 · 166 citations
1660+1+2Years since publication50100150

Peers

Mohammad Sheibani
Comparison fields: 5 of 98
  • Biological Psychiatry 29
  • Endocrine and Autonomic Systems 57
  • Cardiology and Cardiovascular Medicine 176
  • Aging 9
  • Geriatrics and Gerontology 12
Replace Hyeongseok Kim with:
Hyeongseok Kim South Korea
Jana Radošinská Slovakia
Francesc Jiménez‐Altayó Spain
Di Ye China
María Dolores Mauricio Spain
Fei He China
Claire Allen United Kingdom
Patricia Marchio Spain
Rong Jiang China
Xin-Ping Ouyang China
Mohammad Sheibani relative to Hyeongseok Kim South Korea Hyeongseok Kim's profile →
Citations per field
00.5×2.7×
Hyeongseok Kim · 1×
Citations per year

Countries citing papers authored by Mohammad Sheibani

Since Specialization
Citations

This map shows the geographic impact of Mohammad Sheibani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mohammad Sheibani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mohammad Sheibani more than expected).

Fields of papers citing papers by Mohammad Sheibani

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mohammad Sheibani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mohammad Sheibani. The network helps show where Mohammad Sheibani may publish in the future.

Co-authors

The 25 scholars most cited alongside Mohammad Sheibani, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mohammad Sheibani Line = papers co-authored together Mohammad Sheibani links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 60 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Doxorubicin-Induced Cardiotoxicity: An Overview on Pre-clinical Therapeutic Approaches
Hit paper breakdown →
2022166
2 202054
3 202351
4 202325
5 202223
6 202023
7 202221
8 201921
9 202020
10 202319
11 202119
12 202319
13 202317
14 202316
15 201916
16 202215
17 202115
18 202115
19 202314
20
Herbal Medicines and Other Traditional Remedies in Iran - A Tragedy Unfolds.
201814

About Mohammad Sheibani

Mohammad Sheibani is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology, Endocrine and Autonomic Systems, Pulmonary and Respiratory Medicine and Endocrinology, Diabetes and Metabolism, having authored 60 papers that have together received 759 indexed citations. Recurring topics across this work include Circadian rhythm and melatonin (9 papers), Chemotherapy-induced cardiotoxicity and mitigation (7 papers), Metabolism, Diabetes, and Cancer (3 papers), Diabetes Treatment and Management (3 papers), Electron Spin Resonance Studies (3 papers), Blood Pressure and Hypertension Studies (2 papers), Helicobacter pylori-related gastroenterology studies (2 papers) and Phytochemistry and Biological Activities (2 papers). The work is most often cited by research in Biological Psychiatry (29 citations), Endocrine and Autonomic Systems (57 citations), Cardiology and Cardiovascular Medicine (176 citations), Aging (9 citations) and Geriatrics and Gerontology (12 citations). Mohammad Sheibani has collaborated with scholars based in Iran, United States and Armenia. Frequent co-authors include Ahmad Reza Dehpour, Sadaf Nezamoleslami, Maryam Shayan, Yaser Azizi, Mohammad Hadi Farjoo, Faezeh Eslami, Hedyeh Faghir‐Ghanesefat, Mehdi Ghasemi, Azam Hosseinzadeh and Saeed Mehrzadi. Their work appears in journals such as Current Problems in Cardiology, Molecular Biology Reports, Pharmacological Reports, Immunopharmacology and Immunotoxicology and Experimental and Molecular Pathology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact